Atherosclerosis-prone ApoE-/- mice were treated with intraperitoneal injections of MAGL-inhibitor JZL184 in order to investigate the impact of raised 2-AG levels on atherogenesis in vivo. The gene discussed is MGLL; the disease is atherosclerosis.